Aprea Therapeutics
APRE
APRE
20 hedge funds and large institutions have $4.44M invested in Aprea Therapeutics in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Holders
20
Holding in Top 10
–
Calls
$621K
Puts
–
Top Buyers
| 1 | +$206K | |
| 2 | +$93.4K | |
| 3 | +$34.5K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$9 |
| 5 |
JPMorgan Chase & Co
New York
|
+$5 |
Top Sellers
| 1 | -$11.1K | |
| 2 | -$5.64K | |
| 3 | -$3.41K | |
| 4 |
BOC
Bull Oak Capital
San Diego,
California
|
-$162 |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$105 |